References
- Higashi H, Fukutomi T, Watanabe T, Adachi I, Narabayashi M, Shibui S, et al. Seven cases of breast cancer recurrence limited to the central nervous system without other visceral metastases. Breast Cancer 2000; 7: 153–6
- Patanaphan V, Salazar OM, Risco R. Breast cancer. Metastatic patterns and their prognosis. South Med J 1988; 81: 1109–12
- Kallioniemi OP, Holli K, Visakorpi T, Koivula T, Helin HH, Isola JJ. Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer. Int J Cancer 1991; 49: 650–5
- Nussbaum ES, Djalilian HR, Cho KH, Hall WA. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 1996; 78: 1781–8
- Forsyth PA, Posner JB. Headaches in patients with brain tumors: A study of 111 patients. Neurology 1993; 43: 1678–83
- Lassman AB, DeAngelis LM. Brain metastases. Neurol Clin 2003; 21: 1–23
- Lin NU, Bellon JR, Winer EP. CNS metastases in breast cancer. J Clin Oncol 2004; 22: 3608–17
- Davis PC, Hudgins PA, Peterman SB, Hoffman JC, Jr. Diagnosis of cerebral metastases: Double-dose delayed CT vs contrast-enhanced MR imaging. AJNR Am J Neuroradiol 1991; 12: 293–300
- Akeson P, Larsson EM, Kristoffersen DT, Jonsson E, Holtas S. Brain metastases: Comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging. Acta Radiol 1995; 36: 300–6
- DiStefano A, Yong YY, Hortobagyi GN, Blumenschein GR. The natural history of breast cancer patients with brain metastases. Cancer 1979; 44: 1913–8
- Hendrickson FR, Lee MS, Larson M, Gelber RD. The influence of surgery and radiation therapy on patients with brain metastases. Int J Radiat Oncol Biol Phys 1983; 9: 623–7
- Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322: 494–500
- Gerosa M, Nicolato A, Foroni R, Zanotti B, Tomazzoli L, Miscusi M, et al. Gamma knife radiosurgery for brain metastases: A primary therapeutic option. J Neurosurg 2002;97(5 Suppl):515–24.
- Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37: 745–51
- Boogerd W, Vos VW, Hart AA, Baris G. Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neurooncol 1993; 15: 165–74
- Cho SY, Choi HY. Causes of death and metastatic patterns in patients with mammary cancer. Ten-year autopsy study. Am J Clin Pathol 1980; 73: 232–4
- Priestman TJ, Dunn J, Brada M, Rampling R, Baker PG. Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin Oncol (R Coll Radiol) 1996; 8: 308–15
- Evans AJ, James JJ, Cornford EJ, Chan SY, Burrell HC, Pinder SE, et al. Brain metastases from breast cancer: Identification of a high-risk group. Clin Oncol (R Coll Radiol) 2004; 16: 345–9